Asahi Net is the Fir
Asahi Net is the First to Adopt the Allot SG-Tera III Multiservice Platform
December 12, 2024 05:07 ET | Allot
Hod Hasharon, Israel, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Allot Ltd. (NASDAQ: ALLT) (TASE: ALLT), a leading global provider of innovative network intelligence and security-as-a-service (SECaaS)...
Founder Group 携人工智能驱动无人机技术进军 1800 亿美元人工智能市场,聚焦于太阳能电站巡检
December 12, 2024 04:12 ET | Founder Group Limited
吉隆坡,马来西亚, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Founder Group Limited (纳斯达克股票代码:FGL,下称“Founder Group”或“公司”) 是马来西亚领先的太阳能光伏系统工程、采购、建设和调试 (EPCC) 解决方案供应商。公司欣然宣布与 VC AI Limited (下称“VC.AI”)...
briacell-logo-square-a.jpg
BriaCell Therapeutics Announces Pricing of $5.5 Million Public Offering
December 11, 2024 23:54 ET | BriaCell Therapeutics Corp.
PHILADELPHIA and Vancouver, British Columbia, Dec. 11, 2024 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage...
Nutanix-Logo-Charcoal-Gray-Digital.png
Nutanix Announces Pricing of $750 Million 0.50% Convertible Senior Notes
December 11, 2024 23:45 ET | Nutanix, Inc.
SAN JOSE, Calif., Dec. 11, 2024 (GLOBE NEWSWIRE) -- Nutanix, Inc. (“Nutanix”) (Nasdaq: NTNX) , a leader in hybrid multicloud computing, today announced the pricing of $750 million aggregate...
HUTCHMED-small-spaced-1000x305-WhiteBgd.png
HUTCHMED Announces Breakthrough Therapy Designation in China for ORPATHYS® and TAGRISSO® Combination in Certain Lung Cancer Patients After Disease Progression on EGFR Inhibitor Therapy
December 11, 2024 23:00 ET | HUTCHMED (China) Limited
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Dec. 11, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that the Center for Drug Evaluation...
NewAmsterdam Logo_full color_Final.png
NewAmsterdam Pharma Announces Pricing of Upsized $416.5 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
December 11, 2024 21:37 ET | NewAmsterdam Pharma N.V.
NAARDEN, the Netherlands and MIAMI, Dec. 11, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS; “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical...
AMPG Logo.png
AmpliTech Group Announces Pricing of $2.2 Million Registered Direct Offering
December 11, 2024 21:21 ET | AmpliTech Group, Inc.
AmpliTech Group Announces Pricing of $2.2 Million Registered Direct Offering
FISI Logo.jpg
Financial Institutions, Inc. Announces Pricing of Common Stock Offering
December 11, 2024 19:58 ET | Financial Institutions, Inc.
WARSAW, N.Y., Dec. 11, 2024 (GLOBE NEWSWIRE) -- Financial Institutions, Inc. (Nasdaq: FISI) (the “Company”), parent company of Five Star Bank and Courier Capital, LLC, today announced the pricing of...
MG-Logo-Lockup B-Spruce.png
Metagenomi Presents Highly Specific and Efficient Genome Editing Tools at Nature Conference “RNA at the Bench and Bedside IV”
December 11, 2024 18:30 ET | Metagenomi, Inc.
MGX-001, utilizing a highly specific and efficient MG29-1 nuclease, exhibits no identifiable off-target editing MG29-1 nuclease targeting the albumin safe harbor locus showed no evidence of...
NorthView Acquisition Corporation Announces Receipt of Notice from Nasdaq Regarding Filing of Quarterly Report on Form 10-Q
December 11, 2024 18:30 ET | NorthView Acquisition Corp.
New York, NY, Dec. 11, 2024 (GLOBE NEWSWIRE) -- NorthView Acquisition Corporation. (Nasdaq: NVAC) (the “Company”) announced that it has received a notice (the “Notice”) from The Nasdaq Stock Market...